EIM
AMRX icon

Essex Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Essex Investment Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.4K Hold
4,295
– – 0.01% 252
2025
Q4 		$54.1K Buy
+4,295
New +$49.1K 0.01% 251

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Essex Investment Management's AMRX Position: Q1 2026 in Review

Essex Investment Management held its Amneal Pharmaceuticals (AMRX) position steady in Q1 2026 at 4,295 shares worth $53.4K. The position accounts for 0.01% of the portfolio, ranked #252.

Essex Investment Management first reported a position in AMRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $54.1K in Q4 2025. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Essex Investment Management held 4,295 shares of Amneal Pharmaceuticals worth $53.4K as of Q1 2026.
  • Essex Investment Management left its Amneal Pharmaceuticals share count unchanged in Q1 2026.
  • Amneal Pharmaceuticals made up 0.01% of Essex Investment Management's portfolio in Q1 2026, its #252 holding.
  • Essex Investment Management first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Essex Investment Management's Amneal Pharmaceuticals position peaked at $54.1K in Q4 2025.
  • 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Essex Investment Management's 13F filing for Q1 2026, filed 11 May 2026.